Catalyst Pharmaceuticals (CPRX) Other Non-Current Assets (2010 - 2022)

Catalyst Pharmaceuticals has reported Other Non-Current Assets for 13 years, with the latest figure at $9000.0 in Q4 2022.

• For the quarter ending Q4 2022, Other Non-Current Assets changed 0.0% year-over-year to $9000.0; the trailing twelve-month figure through Dec 2022 stood at $9000.0 (changed 0.0% YoY), and the FY2022 full-year result was $9000.0, changed 0.0% from the prior year.
• Other Non-Current Assets for Q4 2022 stood at $9000.0, roughly flat from $9000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $9000.0 in Q4 2020, with the low at $8888.0 in Q1 2018.
• Historically, Other Non-Current Assets has averaged $8938.4 across 5 years, with a median of $8888.0 in 2018.
• Annual changes were most pronounced in 2018 — Other Non-Current Assets changed 0.0% — and 2020, when it climbed 1.26%.
• Catalyst Pharmaceuticals' Other Non-Current Assets stood at $8888.0 in 2018, then changed by 0.0% to $8888.0 in 2019, then climbed by 1.26% to $9000.0 in 2020, then changed by 0.0% to $9000.0 in 2021, then changed by 0.0% to $9000.0 in 2022.
• The last three Other Non-Current Assets figures came in at $9000.0 (Q4 2022), $9000.0 (Q3 2022), and $9000.0 (Q2 2022), per Business Quant data.